In clinical settings, rapamycin is used both as a monotherapy and in combination with other treatments. Its immunosuppressive properties make it valuable in preventing organ transplant rejection. In oncology, rapamycin is often explored in combination with other chemotherapeutic agents to enhance efficacy. For instance, combining rapamycin with tyrosine kinase inhibitors can produce synergistic effects in certain cancers.
